Stay updated on Pembrolizumab for Leptomeningeal Disease Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Leptomeningeal Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Leptomeningeal Disease Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Locations section added with Maryland listed as a site, updating where the trial is conducted. The page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T08:56:28.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    The Publications section now states that publications are automatically filled in from PubMed, and the page revision label shows Revision: v3.3.2 (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:07:07.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The funding-status notice was removed from the page, and the study information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:23:34.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    No additions or deletions to core page content were detected; the study overview, eligibility criteria, and outcomes remain unchanged between the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:05:51.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    - Added a government-status notice and links, indicating current operating status and potential processing delays. - Updated revision version from v3.1.0 to v3.2.0. No other significant content changes detected.
    Difference
    3%
    Check dated 2025-10-13T05:07:24.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T02:56:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Leptomeningeal Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Leptomeningeal Disease Clinical Trial page.